Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Bristol-Myers Squibb Co    BMY

Delayed Quote. Delayed  - 08/23 10:00:31 pm
59.86 USD   +1.01%
08/22 ALLIED MINDS : Given New Debt, Raises Funds For Drug Development
08/21 BRISTOL MYERS S : Fukoku Mutual Life Insurance Co Lowers stake in Br..
08/11DJBusiness Watch -- WSJ
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/17/2016 08/18/2016 08/19/2016 08/22/2016 08/23/2016 Date
58.3(c) 58.68(c) 59.29(c) 59.26(c) 59.86(c) Last
21 007 446 14 693 323 12 134 850 11 133 617 10 575 703 Volume
-1.87% +0.65% +1.04% -0.05% +1.01% Change
More quotes
Financials ($)
Sales 2016 18 890 M
EBIT 2016 4 944 M
Net income 2016 4 379 M
Debt 2016 1 249 M
Yield 2016 2,61%
Sales 2017 20 345 M
EBIT 2017 5 803 M
Net income 2017 5 161 M
Finance 2017 963 M
Yield 2017 2,75%
P/E ratio 2016 22,92
P/E ratio 2017 19,79
EV / Sales2016 5,31x
EV / Sales2017 4,82x
Capitalization 99 015 M
More Financials
Company
Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products.Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from... 
Sector
Pharmaceuticals
Calendar
10/05Ex-dividend day
More about the company
Surperformance© ratings of Bristol-Myers Squibb Co
Trading Rating : Investor Rating :
More Ratings
Latest news on BRISTOL-MYERS SQUIBB CO
08/22 ALLIED MINDS : Given New Debt, Raises Funds For Drug Development
08/21 BRISTOL MYERS SQUIBB : Fukoku Mutual Life Insurance Co Lowers stake in Bristol-M..
08/18 BRISTOL MYERS SQUIBB : Study Results from Bristol-Myers Squibb Provide New Insig..
08/18 EIGER BIOPHARMACEUTICALS : Reports Second Quarter 2016 Financial Results
08/18 BRISTOL MYERS SQUIBB : Announces Top-Line Results from CheckMate -026, a Phase 3..
08/18 BRISTOL MYERS SQUIBB : New Glutamic Acid Study Findings Have Been Reported by In..
08/11 BRISTOL MYERS SQUIBB : Studies from Bristol-Myers Squibb Have Provided New Data ..
08/11 BRISTOL MYERS SQUIBB : Study Data from Bristol-Myers Squibb Update Understanding..
08/11 BRISTOL MYERS SQUIBB : An Application for the Trademark "AZENMI" Has Been Filed ..
08/11 BRISTOL MYERS SQUIBB : Patent Issued for Methods for the Preparation of HIV Atta..
More news
Sector news : Pharmaceuticals - NEC
08/23DJU.S. Lawmakers Plan Hearing Over Wave of Agriculture Mergers
08/23DJPFIZER : to Acquire Key Drug -- WSJ
08/23DJDeal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
08/23DJNew CFO Tops Off Shake-Up At Valeant -- WSJ
08/22DJValeant Names Zoetis Executive as Financial Chief--Update
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
08/23 Game Plan For The Week - Cramer's Mad Money (8/22/16)
08/22 Is The Sky Falling Only On Gilead?
08/19 Play Oncology To Play M&A In Big Pharma?
08/19 Profit From Bristol-Myers' Drug Failure And Increased Volatility
08/17 Slimmed-Down Big Pharma Starts Growing Again
Advertisement
Chart BRISTOL-MYERS SQUIBB CO
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Full-screen chart
Technical analysis trends BRISTOL-MYERS SQU...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 68,8 $
Spread / Average Target 16%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Giovanni Caforio Chief Executive Officer & Director
Lamberto Andreotti Chairman
Charles A. Bancroft Chief Financial Officer & Executive Vice President
Francis M. Cuss Chief Scientific Officer & Executive VP
Paul von Autenried Chief Information Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BRISTOL-MYERS SQUIBB C..-13.85%99 015
JOHNSON & JOHNSON15.98%325 925
ROCHE HOLDING LTD.-12.26%219 531
NOVARTIS AG-10.20%213 663
PFIZER INC.7.93%211 327
MERCK & CO., INC.20.31%175 729
More Results